131 related articles for article (PubMed ID: 24464432)
21. Targeting the Ataxia Telangiectasia Mutated Protein in Cancer Therapy.
Vecchio D; Frosina G
Curr Drug Targets; 2016; 17(2):139-53. PubMed ID: 25382204
[TBL] [Abstract][Full Text] [Related]
22. Regulation of ATM in DNA double strand break repair accounts for the radiosensitivity in human cells exposed to high linear energy transfer ionizing radiation.
Xue L; Yu D; Furusawa Y; Okayasu R; Tong J; Cao J; Fan S
Mutat Res; 2009 Nov; 670(1-2):15-23. PubMed ID: 19583974
[TBL] [Abstract][Full Text] [Related]
23. Checkpoint kinase 2 (Chk2) supports sensitivity to platinum-based treatment in high grade serous ovarian cancer.
Alkema NG; Tomar T; van der Zee AG; Everts M; Meersma GJ; Hollema H; de Jong S; van Vugt MA; Wisman GB
Gynecol Oncol; 2014 Jun; 133(3):591-8. PubMed ID: 24657486
[TBL] [Abstract][Full Text] [Related]
24. Ionizing radiation activates the ATM kinase throughout the cell cycle.
Pandita TK; Lieberman HB; Lim DS; Dhar S; Zheng W; Taya Y; Kastan MB
Oncogene; 2000 Mar; 19(11):1386-91. PubMed ID: 10723129
[TBL] [Abstract][Full Text] [Related]
25. An HTRF
Adams P; Clark J; Hawdon S; Hill J; Plater A
Methods Mol Biol; 2017; 1599():43-56. PubMed ID: 28477110
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and Characterization of Quinoline-3-Carboxamide Derivatives as Inhibitors of the ATM Kinase.
Ravi S; Barui S; Kirubakaran S; Duhan P; Bhowmik K
Curr Top Med Chem; 2020; 20(23):2070-2079. PubMed ID: 32735523
[TBL] [Abstract][Full Text] [Related]
27. Anti-Tumorigenic Activity of Chrysin from
Nagasaka M; Hashimoto R; Inoue Y; Ishiuchi K; Matsuno M; Itoh Y; Tokugawa M; Ohoka N; Morishita D; Mizukami H; Makino T; Hayashi H
Molecules; 2018 Jun; 23(6):. PubMed ID: 29890668
[TBL] [Abstract][Full Text] [Related]
28. Sensors and Inhibitors for the Detection of Ataxia Telangiectasia Mutated (ATM) Protein Kinase.
Huang C; Filippone NR; Reiner T; Roberts S
Mol Pharm; 2021 Jul; 18(7):2470-2481. PubMed ID: 34125542
[TBL] [Abstract][Full Text] [Related]
29. Selenite activates the ATM kinase-dependent DNA repair pathway in human osteosarcoma cells with mitochondrial dysfunction.
Wojewoda M; Walczak J; Duszyński J; Szczepanowska J
Biochem Pharmacol; 2015 Jun; 95(3):170-6. PubMed ID: 25862479
[TBL] [Abstract][Full Text] [Related]
30. Discovery of Novel 3-Quinoline Carboxamides as Potent, Selective, and Orally Bioavailable Inhibitors of Ataxia Telangiectasia Mutated (ATM) Kinase.
Degorce SL; Barlaam B; Cadogan E; Dishington A; Ducray R; Glossop SC; Hassall LA; Lach F; Lau A; McGuire TM; Nowak T; Ouvry G; Pike KG; Thomason AG
J Med Chem; 2016 Jul; 59(13):6281-92. PubMed ID: 27259031
[TBL] [Abstract][Full Text] [Related]
31. ATM Kinase Inhibitors: HTS Cellular Imaging Assay Using Cellomics™ ArrayScan VTI Platform.
Bardelle C; Boros J
Methods Mol Biol; 2017; 1599():57-70. PubMed ID: 28477111
[TBL] [Abstract][Full Text] [Related]
32. Preclinical evaluation of a novel ATM inhibitor, KU59403, in vitro and in vivo in p53 functional and dysfunctional models of human cancer.
Batey MA; Zhao Y; Kyle S; Richardson C; Slade A; Martin NM; Lau A; Newell DR; Curtin NJ
Mol Cancer Ther; 2013 Jun; 12(6):959-67. PubMed ID: 23512991
[TBL] [Abstract][Full Text] [Related]
33. Vitamin C increases DNA breaks and suppresses DNA damage-independent activation of ATM by bleomycin.
Rubis B; Luczak MW; Krawic C; Zhitkovich A
Free Radic Biol Med; 2019 May; 136():12-21. PubMed ID: 30926564
[TBL] [Abstract][Full Text] [Related]
34. ATM in DNA repair in cancer.
Jin MH; Oh DY
Pharmacol Ther; 2019 Nov; 203():107391. PubMed ID: 31299316
[TBL] [Abstract][Full Text] [Related]
35. ATM kinase: Much more than a DNA damage responsive protein.
Guleria A; Chandna S
DNA Repair (Amst); 2016 Mar; 39():1-20. PubMed ID: 26777338
[TBL] [Abstract][Full Text] [Related]
36. A novel cell-based screening assay for small-molecule MYB inhibitors identifies podophyllotoxins teniposide and etoposide as inhibitors of MYB activity.
Yusenko M; Jakobs A; Klempnauer KH
Sci Rep; 2018 Sep; 8(1):13159. PubMed ID: 30177851
[TBL] [Abstract][Full Text] [Related]
37. Chemical inhibition of DNA repair kinases as a promising tool in oncology.
Durisova K; Salovska B; Pejchal J; Tichy A
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2016 Mar; 160(1):11-9. PubMed ID: 26498210
[TBL] [Abstract][Full Text] [Related]
38. High-throughput screens for eEF-2 kinase.
Devkota AK; Warthaka M; Edupuganti R; Tavares CD; Johnson WH; Ozpolat B; Cho EJ; Dalby KN
J Biomol Screen; 2014 Mar; 19(3):445-52. PubMed ID: 24078616
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of cytotoxicity and DNA damage response with analysis of intracellular ATM signaling pathways.
Bandi S; Viswanathan P; Gupta S
Assay Drug Dev Technol; 2014 Jun; 12(5):272-81. PubMed ID: 24927134
[TBL] [Abstract][Full Text] [Related]
40. The Identification of Potent, Selective, and Orally Available Inhibitors of Ataxia Telangiectasia Mutated (ATM) Kinase: The Discovery of AZD0156 (8-{6-[3-(Dimethylamino)propoxy]pyridin-3-yl}-3-methyl-1-(tetrahydro-2 H-pyran-4-yl)-1,3-dihydro-2 H-imidazo[4,5- c]quinolin-2-one).
Pike KG; Barlaam B; Cadogan E; Campbell A; Chen Y; Colclough N; Davies NL; de-Almeida C; Degorce SL; Didelot M; Dishington A; Ducray R; Durant ST; Hassall LA; Holmes J; Hughes GD; MacFaul PA; Mulholland KR; McGuire TM; Ouvry G; Pass M; Robb G; Stratton N; Wang Z; Wilson J; Zhai B; Zhao K; Al-Huniti N
J Med Chem; 2018 May; 61(9):3823-3841. PubMed ID: 29683659
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
